ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

CING Cingulate Inc

1.04
0.12285 (13.39%)
May 01 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 62,140
Bid Price 0.979
Ask Price 1.04
News -
Day High 1.04

Low
0.75

52 Week Range

High
23.40

Day Low 0.96
Share Name Share Symbol Market Stock Type
Cingulate Inc CING NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.12285 13.39% 1.04 17:40:41
Open Price Low Price High Price Close Price Previous Close
0.96 0.96 1.04 1.04 0.91715
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
240 62,140 US$ 0.9871987 US$ 61,345 - 0.75 - 23.40
Last Trade Type Quantity Price Currency
18:22:38 formt 454 US$ 1.04 USD

Cingulate Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
974.48k 937.00k - 0 -23.54M -25.12 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cingulate News

Date Time Source News Article
4/30/202404:45GlobeNewswire Inc.Peter J. Werth, Successful Pharma Entrepreneur,..
4/16/202416:00GlobeNewswire Inc.Cingulate to Participate in Planet MicroCap Showcase: Vegas..
4/01/202407:00GlobeNewswire Inc.Cingulate Inc. Reports Fourth Quarter and Full Year 2023..
3/19/202415:45GlobeNewswire Inc.Cingulate to Participate in Benzinga All Live Access Event
3/06/202417:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/06/202417:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/06/202417:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/06/202417:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/06/202417:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/06/202417:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/06/202405:45GlobeNewswire Inc.Cingulate to Attend DCAT Week 2024 in New York City
2/26/202406:00Edgar (US Regulatory)Form 8-K - Current report
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CING Message Board. Create One! See More Posts on CING Message Board See More Message Board Posts

Historical CING Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.85781.040.82740.870485328,2750.182221.24%
1 Month1.061.100.750.922423887,453-0.02-1.89%
3 Months1.301.500.751.14205,175-0.26-20.00%
6 Months8.45412.700.755.21911,812-7.41-87.70%
1 Year21.4023.400.757.68596,946-20.36-95.14%
3 Years100.00103.000.7519.05411,048-98.96-98.96%
5 Years100.00103.000.7519.05411,048-98.96-98.96%

Cingulate Description

Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.

Your Recent History

Delayed Upgrade Clock